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Wetestedthehypothesisthat,inacutemetabolicacidemia,thefetalleftventricle(LV)hasthecapacitytoincreaseitscontractilityin
response to angiotensin II infusion. Eleven ewes and their fetuses were instrumented at 127–138/145 days of gestation. The eﬀect
of angiotensin II on fetal LV function was assessed using intraventricular pressure catheter and tissue Doppler imaging (TDI).
Angiotensin II increased fetal arterial blood pressure, whereas pH and pO2 decreased. The heart rate and systemic venous pressure
were not aﬀected signiﬁcantly. The LV end-diastolic and end-systolic pressures, as well as dP/dtmax, increased. The TDI-derived
LV longitudinal myocardial isovolumic contraction velocity and its acceleration and velocity during early ﬁlling were higher than
those at baseline. The incidence of absent isovolumic relaxation velocity was greater during angiotensin II infusion. In summary,
during acute metabolic acidemia, the fetal left ventricle could increase its contractility in response to inotropic stimulus even in
the presence of increased afterload. The diastolic LV function parameters were altered by angiotensin II.
1.Introduction
Experimental studies have shown that sheep fetuses with
increased placental vascular resistance and acute metabolic
acidosis are able to maintain right and left ventricular (LV)
cardiac outputs [1]. However, they show signs of impaired
myocardial contractility during the isovolumic contraction
phase and impaired relaxation during the isovolumic and
early diastolic ﬁlling phases of the cardiac cycle. The global
fetal cardiac function is preserved during moderate acidemia
despite reduced myocardial contractility [1].
Angiotensin II is an important short- and long-term
regulator of blood pressure. It is evident that angiotensin II,
in addition to its peripheral vasoconstrictive eﬀect, has pos-
itiveinotropicandchronotropiceﬀectsontheheartindepen-
dent of arterial blood pressure [2]. However, the inotropic
response to angiotensin II in cardiac muscle can vary; the
responsiveness seems to be greater in the normal healthy
myocardium than in the failing muscle [3]. In fact, in adult
dogswithpacing-inducedheartfailure,angiotensinIIcaused
a direct depression in the LV contraction and relaxation and
exacerbated the reduced myocyte contractile performance
[4]. In addition, myocardial tissue preparations have shown
altered responses to angiotensin II after acute myocardial
infarction [5]. In humans, several pregnancy complications
including placental insuﬃciency are associated with fetal2 Journal of Pregnancy
hypoxia and metabolic acidosis. Furthermore, asphyxiated
term infants commonly have biochemical and echocardio-
graphic evidence of abnormal cardiac function [6], and tis-
sueDopplerimaging(TDI)appearstobemoresensitivethan
conventional measurement of fractional shortening in early
detection of myocardial dysfunction induced by perinatal
asphyxia [6, 7]. In the present acute experimental model
on near-term sheep fetuses, we tested the hypothesis that in
acutefetalmetabolicacidemiaLVhasthecapacitytoincrease
its contractility during angiotensin II infusion. Speciﬁcally,
we asked the following questions: (1) does angiotensin II
infusion increase LV pressure generation and contractility
measured by an intraventricular pressure catheter and (2)
does angiotensin II infusion aﬀect tissue Doppler-derived
parameters of the LV systolic and diastolic function in the
presence of increased ventricular afterload?
2.MaterialsandMethods
Eleven ewes of Finnish breed with time-dated pregnancies
between 127 and 138 days of gestation (term gestation 145
days) were included in this study. All experiments were per-
formed in accordance with the guidelines of the European
Convention for the Protection of Vertebrate Animals Used
for Experimental and Other Scientiﬁc Purposes (1986)
and in compliance with the European Union Directive
86/609/EEC (1997). The research protocol was approved by
the Animal Care and Use Committee of the University of
Oulu, Finland.
Before surgery, food was withdrawn for 18 hours. Intra-
muscular ketamine (2mg/kg) and midazolam (0.2mg/kg)
were given for premedication half an hour before anesthesia.
Left external jugular vein was cannulated for intravenous
access, and Ringer’s lactate solution was infused at a rate
of 200mL/hour. General anesthesia was induced with intra-
venous propofol (4–7mg/kg). The anesthesia was main-
tained with isoﬂurane (1.5–2.5%) in a 40% oxygen-air mix-
ture delivered via an endotracheal tube. Mechanical ventila-
tionwasmaintainedwithaSiemens730ventilator(Siemens-
Elema AB, Solna, Sweden). Tidal volume was adjusted to
10mL/kg and respiratory rate to 18/minute. Maternal femo-
ral artery was cannulated to measure the arterial blood pres-
sure (BP), heart rate, and acid-base status.
A midline laparotomy was performed and a fetal hind-
limb was delivered through a small uterine incision. 4F poly-
urethane catheters (BD Careﬂow, Becton Dickinson Medical
Systems, Singapore) were introduced into the fetal inferior
vena cava and descending aorta via femoral vein and artery,
respectively. The fetal limb was returned into the uterus, and
the uterine incision was closed with a purse-string suture.
A separate small incision was made on the uterus to
access the fetal neck. Right carotid artery was dissected, and
a 5F cannula with a back ﬂow valve was introduced using
a guide wire and introducer. A 3F Millar SPR877 catheter
(Millar Instruments, Houston, Tex, USA) was advanced into
the fetal LV through the 5F cannula. The position of the
catheter within the LV cavity was conﬁrmed by ultrasonog-
raphy. The micromanometer pressure transducer output was
fed to a custom-built ampliﬁer and connected to a signal-
processing unit (Sigma 5DF, Cardiodynamics corp.) for the
continuous measurement of LV pressure.
Maternal arterial BP, heart rate, and oxygen saturation
(SaO2) and fetal BP, heart rate, and central venous pressure
(CVP) were recorded continuously at a 100Hz sampling rate
using a polygraph (UIM100A, Biopac Systems Inc., Santa
Barbara,Calif,USA)andcomputerizeddataacquisitionsoft-
ware (Acqknowledge v. 3.5.7 for Windows, Biopac Systems
Inc., Santa Barbara, Calif, USA). Acid-base status was
checked (corrected to 39◦C) at the end of baseline and an-
giotensin II phases using an Abbot i-sat 1 arterial blood gas
analyser (i-Stat, East Windsor, NJ, USA).
Ultrasonography was performed using the Vivid 7 Di-
mension ultrasound system (GE Vingmed Ultrasound,
Horten, Norway) with a 10MHz-phased array transducer
through the uterine wall. Mitral valve’s blood ﬂow velocity
waveforms were obtained using pulsed-wave Doppler to
measure the maximum velocity of the blood ﬂow during
early ﬁlling (E) of the LV. Longitudinal myocardial velocities
were recorded from the LV lateral wall at the level of mitral
valve annulus using pulsed-wave tissue Doppler imaging
(TDI) with the sample volume (1–1.5mm) aligned parallel
to the myocardial wall (insonation angle <15 degrees) at a
sweep speed of 100mm/s. All the ultrasonographic examina-
tions were performed by a single investigator.
Tissue Doppler recordings were analyzed oﬄine using
dedicated software (EchoPac PC v.6.1.2, GE Medical Sys-
tems). The LV maximal longitudinal myocardial velocities
were measured during the isovolumic contraction (IVCV),
ventricular systole (S ), isovolumic relaxation (IVRV), early
ventricular ﬁlling (E ), and atrial contraction (A ) phases
of the cardiac cycle (Figure 1). The isovolumic myocardial
acceleration and deceleration were calculated by dividing the
peak IVCV and IVRV by the time intervals from the onset
to the peak of these velocity waveforms, respectively [1].
The LV isovolumic contraction (IVCT) and relaxation times
(IVRT) were measured, and their proportions (%) of the
total cardiac cycle were calculated as described previously
[1]. To improve measurement precision, the sweep speed of
the Doppler recordings was adjusted according to the fetal
heart rate (i.e., increased to 200mm/s if the fetal heart rate
exceeded 160beats/min) during oﬄine analysis.
Following baseline measurements, 4mL of angiotensin
II solution (1.67mcg/mL) was diluted with 96mL of 0.9%
saline and infused into the fetal inferior vena cava at a rate of
100–200ml/hour (adjusted to keep the fetal MAP increased
at 15–20mmHg above the baseline) and all the above
measurements were repeated. The angiotensin II infusion
was continued for approximately 20 minutes until all the
measurements were made. At the end of the experiment,
the animals were euthanized with an intravenous overdose
(1mg/kg) of pentobarbital sodium. Fetal weight was post-
mortem determined. Data were analysed using Statistical
Software for Social Sciences for windows version 16.0 (SPSS
Inc. Chicago, Ill, USA). To examine diﬀerences between the
baseline and the angiotensin II phase, the paired sample
t-test was used for continuous parametric variables andJournal of Pregnancy 3
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Figure 1: Tissue Doppler-derived left ventricular longitudinal myocardial velocities at the level of mitral valve annulus obtained from a
near-term sheep fetus. Isovolumic contraction velocity (IVCV), isovolumic contraction time (IVCT), velocity during ventricular systole (S ),
isovolumic relaxation velocity (IVRV), isovolumic relaxation time (IVRT), ejection time (ET), velocities during early ventricular ﬁlling (E ),
a n da t r i a lc o n t r a c t i o n( A  ) phases of the cardiac cycle.
Table 1: Invasively monitored maternal hemodynamic parameters and acid-base status at baseline and during fetal angiotensin II infusion.
Data are presented as mean (SD).
Baseline Angiotensin II P value
Heart rate, beats/min 98 (15) 98 (19) 0.807
Systolic BP, mmHg 95 (7) 94 (109) 0.283
Diastolic BP, mmHg 64 (9) 62 (11) 0.460
Mean arterial pressure, mmHg 74 (8) 72 (11) 0.402
Oxygen saturation, % 95 (4.5) 94 (4.4) 0.115
pH 7.36 (0.03) 7.37 (0.02) 0.115
Base excess, mmol/L −3.18 (3.2) −2.36 (2.1) 0.203
PCO2, kPa 5.13 (0.92) 5.13 (0.43) 0.990
PO2, kPa 14.5 (4.3) 13 (4.1) 0.033
Lactate, mmol/L 0.64 (0.22) 0.65 (0.24) 0.832
the Fisher’s exact test for categorical variables. Statistical sig-
nificance level was set at a P value ≤ 0.05.
3. Results
The mean body weight of the ewes was 67 (range, 52–84) kg
and the mean fetal weight was 2787 (range, 2090–3700)g.
The mean gestational age was 132 days. Maternal blood pres-
sures and acid-base values remained unchanged during the
experiment (Table 1). During angiotensin II infusion fetal
systolic, mean, and diastolic blood pressures increased sig-
niﬁcantly. Fetal heart rate and systemic venous pressure were
not aﬀected by angiotensin II infusion. Fetal pH and pO2
values decreased signiﬁcantly during the experiment (Table
2).Therewasalmostatwo-foldincreaseinLVdP/dtmax (P<
0.003) during angiotensin II infusion. In addition, LV end-
diastolic and end-systolic pressures increased signiﬁcantly
(Table 3). Angiotensin II infusion signiﬁcantly increased
TDI-deri v edL VIV CVandE   velocity(Figure 2).Inaddition,
the LV isovolumic myocardial acceleration demonstrated
over a two-fold increase (P<0.02) during angiotensin II
infusion. The LV E/E  ratio decreased (P<0.02). The in-
cidence of absent IVRV was higher (P<0.02) during angiot-
ensin II infusion (Figure 3). LV IVCT% and IVRT% did not
change signiﬁcantly during the experiment (Table 4).
4. Discussion
The rationale for performing this experimental study was to
investigate the functional capacity and reserve of the fetal
LV during acute metabolic acidemia. We demonstrated that
in the fetal sheep at near-term gestation the LV was able to
increase its contractility in response to angiotensin II infu-
sion despite fetal acidemia and increased cardiac afterload. A
positive response to inotropic stimulus may indicate that the
myocardial dysfunction is transient, and there is a potential
for recovery whereas the chances of recovery may be poor
when the response is negative. Angiotensin II was chosen
because it has a positive inotropic eﬀect on the heart, and
it is a potent peripheral vasoconstrictor. In the fetal sheep, it
increases myocardial blood ﬂow and cardiac output despite a
signiﬁcant increase in afterload [8].
We found that during angiotensin II infusion the fetal LV
dP/dtmax, end-diastolic and end-systolic pressures as well as
the arterial blood pressures increased signiﬁcantly, but the
fetal central venous pressure increase was not signiﬁcant.
Theseﬁndingsareinagreementwithpublishedexperimental
studies on several diﬀerent adult animal species. Angiotensin
IIisknowntoincreasethevenousreturn,and,bythismecha-
nism, it can lead to elevated preload and left ventricular end-
diastolic pressure [9, 10]. In addition, increased LV dP/dtmax4 Journal of Pregnancy
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Figure 2: Tissue Doppler-derived left ventricular longitudinal myocardial velocities at the level of mitral valve annulus at baseline (a) and
during angiotensin II infusion (b). Note an increase in myocardial isovolumic contraction (IVCV) and early ventricular ﬁlling (E ) velocities
and a decrease in myocardial isovolumic relaxation velocity (IVRV) during angiotensin II infusion.
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Figure 3: Tissue Doppler-derived left ventricular longitudinal myocardial velocities at the level of mitral valve annulus during angiotensin
II infusion demonstrating absence of myocardial isovolumic relaxation velocity (IVRV).
suggests that angiotensin II infusion improved ventricular
contractility. Even though dP/dtmax is relatively insensitive
to alterations in afterload, it can be aﬀected by changes in
preload [11, 12]. This could partially explain the increase in
LV dP/dtmax.
One of the main ﬁndings of the present study is that
during angiotensin II infusion TDI-derived LV longitudinal
IVCV and its acceleration increased signiﬁcantly. Both of
these indices describe preejection events in the myocardium
and, thus, are less inﬂuenced by afterload than ejection phase
indices. In fact, experimental animal studies have shown
that the isovolumic myocardial acceleration is independent
of cardiac loading conditions [13]. Our results demonstrate
that fetal LV can increase its contractility in the presenceJournal of Pregnancy 5
Table 2: Invasively monitored fetal hemodynamic parameters and acid-base status at baseline and during angiotensin II infusion. Data are
presented as mean (SD).
Parameter Baseline Angiotensin II P value
Heart rate, beats/min 153 (41) 170 (40) 0.337
Systolic BP, mmHg 55 (8) 83 (18) <0.001
Diastolic BP, mmHg 38 (5) 56 (12) <0.001
Mean arterial pressure, mmHg 43 (6) 65 (14) <0.001
Central venous pressure, mmHg 9 (2) 14 (13) 0.327
pH 7.11 (0.12) 7.04 (0.16) 0.003
Base excess, mmol/L −9.4 (5.0) −11.7 (6.96) 0.029
PCO2, kPa 8.6 (2.3) 9.3 (2.3) 0.020
PO2, kPa 2.4 (0.9) 1.5 (0.8) 0.004
Lactate, mmol/L 7.6 (3.7) 7.4 (2.8) 0.701
Table 3: Fetal left ventricular pressures at baseline and during angiotensin II infusion. Data are presented as mean (SD).
Baseline Angiotensin II P value
dP/dtmax, mmHg/s 1224 (330) 2030 (476) 0.003
End-systolic pressure, mmHg 64 (18) 93 (26) 0.001
End-diastolic pressure, mmHg 14 (6) 20 (9) 0.005
of fetal metabolic acidemia and elevated cardiac afterload.
This is also supported by the unchanged IVCT% during the
angiotensin II infusion. The IVCT characterizes the period
that is needed for the ventricle to increase its pressure from
an atrial to a systemic level. During angiotensin II infusion,
the pressure gradient between LV end-diastolic pressure and
arterial diastolic blood pressure was greater than at baseline
suggestingthattheLVwasabletoimproveitspressuregener-
ation.Experimentalstudiesonadultpigsundernormoxemic
conditions have shown that angiotensin II infusion has a
positive inotropic eﬀect on the LV independent of arterial
blood pressure levels [2]. However, the inotropic response
seems to vary, being greater in the healthy myocardium than
in the failing muscle [3]. In fact, it has been demonstrated
that tachycardia-induced heart failure alters LV and myocyte
responses to angiotensin II, so that angiotensin II produces
directdepressionofLVcontractilityandexacerbatesmyocyte
contractile dysfunction [4]. Altogether, our study suggests
that, in metabolic acidemia, fetal LV can increase its con-
tractility in response to an inotropic stimulus even in the
presence of increased afterload demonstrating the systolic
functional reserve of the fetal LV. The second important
ﬁnding of our experimental study is that during angiotensin
II infusion IVRV was absent signiﬁcantly more often than at
baselinecondition.Previously,wehaveshownthatacutefetal
metabolic acidemia decreases myocardial lengthening veloc-
ity during isovolumetric relaxation [1] suggesting that meta-
bolic acidosis adversely aﬀects the calcium- and energy-
dependentactivemyocardialrelaxation.Signiﬁcantmetabol-
ic acidosis can lead to depletion of myocardial glycogen and
ATP stores that are associated with impaired repolarization.
In addition, angiotensin II itself seems to have a detrimental
eﬀect on isovolumetric cardiac diastolic function possibly by
ad e c r e a s ei nC a 2+ eﬄux through the Na+/Ca2+ exchanger
produced by the angiotensin-II-induced prolongation of
the action potential duration [14]. We suggest that the ear-
ly sign of fetal cardiac diastolic dysfunction could be dimin-
ished myocardial lengthening velocity during isovolumetric
relaxation period. When diastolic function further deterio-
rates, isovolumetric myocardial lengthening velocity disap-
pears. In the present study, IVRT% did not change during
theangiotensinIIinfusion.IVRTrepresentsthetimeinterval
that is needed for the ventricle to decrease its pressure from
a systemic to an atrial level. It seems that IVRT% is not as
sensitive indicator of myocardial diastolic function as my-
ocardial lengthening velocity, and IVRT% can be more
aﬀected by ventricular loading conditions than the myocar-
dialmovementitself.Disturbancesindiastolicfunctionoften
precede the changes in global cardiac systolic performance,
and the assessment of cardiac diastolic function could be
useful in monitoring fetuses at risk for cardiac dysfunction.
Our present study suggests that the absence of IVRV could
be an early sign of abnormal ventricular diastolic function in
the fetus.
I nt h ep r e s e n ts t u d y ,l e f tv e n t r i c u l a rE  -wave velocity
increased signiﬁcantly during angiotensin II infusion. E -
wave velocity is used as an index of active ventricular relax-
ation, but it is also sensitive to changes in ventricular load-
ing conditions. Our results demonstrate that angiotensin
II infusion increased fetal LV preload, and we suggest that
increased E -wave velocity mainly reﬂected elevated ventric-
ular preload. However, as acidemia with increased afterload
is known to decrease mitral E -wave velocity [1], it could
be argued that angiotensin II overcomes the negative eﬀect
of acidosis on myocardial relaxation during early ventricular
ﬁlling. This is also supported by the fact that E/E  ratio was
lower during angiotensin II infusion compared to baseline
despite increased LV end-diastolic pressure. However, in the
fetus, the ventricular ﬁlling occurs mainly during the atrial
contraction rather than in early diastole, and E/E  ratio6 Journal of Pregnancy
Table 4: Fetal left ventricular tissue Doppler-derived parameters at baseline and during angiotensin II infusion. Data are presented as mean
(SD) or n (%).
Baseline Angiotensin II P value
IVCV, cm/s 4.1 (2.3) 6.4 (2.4) 0.039
IVCVAccel, cm/s2 350 (250) 780 (490) 0.022
S -velocity, cm/s 4.7 (1.5) 5.7 (2.4) 0.165
IVRV, cm/s 2.2 (1.4) 0.6 (1.5) 0.15
Absent IVRV, n (%) 2 (20) 8 (80) 0.024
E -velocity, cm/s 3.1 (0.74) 4.4 (0.83) 0.015
A -velocity, cm/s 8.2 (4.0) 12.9 (6.5) 0.073
E/E  ratio 8.7 (2.0) 5.7 (2.1) 0.015
IVCT% 10.4 (4.2) 12.6 (4.8) 0.166
IVRT% 13.3 (7.8) 12.3 (6.1) 0.745
IVCV, isovolumic contraction velocity; IVCVAccel, isovolumic myocardial acceleration; S -velocity, myocardial velocity during the left ventricular systole;
IVRV,isovolumicrelaxationvelocity;E -velocity,myocardialvelocityduringearlyventricularﬁlling;A -velocity,myocardialvelocityduringatrialcontraction;
IVCT, isovolumic contraction time; IVRT, isovolumic relaxation time.
may not reﬂect LV end-diastolic pressure as in adults [15].
LV myocardial velocity during atrial contraction (A -wave
velocity) did not change signiﬁcantly during angiotensin
II infusion. This could suggest that angiotensin II did not
signiﬁcantly augment atrial contraction. However, A -wave
velocity is also aﬀected by changes in ventricular loading
conditions. LV peak S -wave velocity describes myocardial
shortening during the ejection phase of the systole. In
adults, S -wave velocity correlates with ventricular ejection
fraction, and it has been used as an index of cardiac systolic
function [16]. In the present study, we found no signiﬁcant
increase in this parameter, despite signiﬁcantly improved
LV contractility. Myocardial S -wave velocity is sensitive to
changes in the afterload. Increased systemic arterial blood
pressure and LV afterload could have blunted the positive
inotropic eﬀect of angiotensin II on myocardial S -wave
velocity. It appears that these load-dependent parameters of
myocardial lengthening and shortening may not be as useful
in the evaluation of fetal cardiac function as in adults.
The present study has certain limitations. The experi-
ments were performed under general anesthesia. Isoﬂurane
maymodifyfetalcardiovascularregulation.However,studies
on newborn lambs under isoﬂurane anesthesia have shown
that lambs can increase cardiovascular performance during
stress [17]. We used an acute animal preparation in order to
acquire intraventricular pressure measurements simultane-
ously with TDI. The fetuses were acidemic at baseline as
a result of surgical intervention, manipulation, and instru-
mentation. As acute acidemia may alter fetal hemodynamic,
metabolic, and endocrine responses [18], it can be argued
that some of the changes in the left ventricular function
observed in our sheep fetuses following angiotensin II in-
fusion may have been caused by possible release of cate-
cholamines.Althoughfetalplasmacatecholaminelevelswere
not measured, the mean values of the load-independent TDI
parameters measured at baseline in the present study were
similar to those obtained in our previous study with chronic
animal preparation during comparable fetal metabolic aci-
demia demonstrating the validity of our experimental model
[1]. Care was taken to minimize methodological errors
related to TDI measurements. However, a fetal electrocar-
diogram was not obtained simultaneously with tissue Dop-
pler recording. Although diﬀerent phases of cardiac cycle can
be easily identiﬁed on a myocardial tissue Doppler’s velocity
envelope, a simultaneous electrocardiogram could improve
precision. The sample volume was placed accurately at the
level of mitral valve annulus, and the angle of insonation was
kept <15 degrees in all cases during repeated measurements.
The highest available frame rates were used when obtaining
TDI-derived measurements. Finally, all the TDI measure-
ments were obtained by a single investigator. In human fe-
tuses, intraobserver variability of TDI-derived myocardial
velocity measurements has been shown to be comparable to
pulse Doppler-derived parameters [19].
In conclusion, by using an acute experimental fetal sheep
model at near-term gestation, we demonstrated that, in met-
abolic acidemia, the fetal LV can increase its contractility
in response to inotropic stimulus even in the presence of
increased afterload demonstrating the systolic functional
reserve of the fetal LV. However, LV diastolic function dur-
ing the isovolumic phase was disturbed by angiotensin II
infusion.
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